Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: Single center study in Egypt

Table 2 Hepatitis B virus markers profile of hepatitis B virus surface antigen positive pregnant women recruited in the study

Study ID	HBsAg	HBeAg	HBeAb	PCR	HBsAb	HBcIgM	HBcTotal
2	+ve	-ve	+ve	+ve (509)	-ve	-ve	+ve
4	+ve	-ve	+ve	+ve (213)	-ve	-ve	+ve
7	+ve	-ve	+ve	+ve (90)	-ve	-ve	+ve
8	+ve	-ve	+ve	+ve (2530)	-ve	-ve	+ve
9	+ve	-ve	+ve	+ve (147)	-ve	-ve	+ve
13	+ve	+ve	-ve	+ve (54700)	-ve	-ve	+ve
14	+ve	-ve	+ve	+ve (387)	-ve	-ve	+ve
15	+ve	-ve	+ve	+ve (1790)	-ve	-ve	+ve
16	+ve	-ve	+ve	+ve (12500)	-ve	-ve	+ve
17	+ve	+ve	-ve	+ve (314000)	-ve	-ve	+ve
18	+ve	-ve	+ve	+ve (989000000)	-ve	-ve	+ve
21	+ve	-ve	+ve	+ve (832)	-ve	-ve	+ve
23	+ve	-ve	+ve	+ve (4010)	-ve	-ve	+ve
26	+ve	+ve	-ve	+ve (39000000)	-ve	-ve	+ve
28	+ve	-ve	+ve	+ve (79)	-ve	-ve	+ve
30	+ve	-ve	+ve	+ve (272)	-ve	-ve	+ve
31	+ve	-ve	-ve	+ve (64)	-ve	-ve	+ve
35	+ve	-ve	+ve	+ve (72)	-ve	-ve	+ve

Cases number 1, 3, 5, 6, 10-12, 19, 20, 22, 24, 25, 27, 29, 32-34 were positive for hepatitis B virus surface antigen (HBsAg) and HBcTotal, and negative for hepatitis B surface antibodies (HBsAb), hepatitis B core antigen IgM (HBcIgM), hepatitis B e antigen (HBeAg), hepatitis B e antibody (HBeAb) and hepatitis B virus (HBV) PCR.